NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index; 13 of the 27 sources its claims cite were checked for support.
Abstract
Here we show that nicotinamide riboside kinase 1 (NRK1) is necessary and rate-limiting for the use of exogenous NR and NMN for NAD+ synthesis. Using stable isotope-labelled compounds, we confirm NMN is metabolized extracellularly to NR that is then taken up by the cell and converted into NAD+.
Overview
CoChat Summary
## TL;DR
NRK1 is the key rate-limiting enzyme that mammalian cells and liver require to convert exogenous nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) into NAD+. The paper shows that NMN is first dephosphorylated extracellularly to NR, which is then taken up and used for NAD+ synthesis.
## Key findings
- In NIH/3T3 cells, overexpression of active NRK1 or NRK2 converted NR-nonresponsive cells into NR-responsive cells, producing about a 4-fold increase in NAD+; catalytically inactive NRK1-D36A and NRK2-D35A did not.
- In F3T3-NRK1 cells, NR increased NAD+ at concentrations as low as 100 μM, with maximal effects at about 1 mM; NMN increased NAD+ only in NRK1-overexpressing cells and less potently than NR, while NAM worked regardless of NRK1.
- In primary hepatocytes from NRK1KO mice, NR and NMN failed to increase NAD+, whereas NA and NAM still increased NAD+ normally.
- In vivo, 500 mg kg−1 intraperitoneal NR raised liver NAD+ by about 220% in wild-type mice; NMN and NAM raised it by about 170%, and NR/NMN responses were significantly blunted in NRK1KO mice, though about 60% of the NR and NMN effect remained.
## Methods
- The study used gain- and loss-of-function models: transient and stable NRK1/NRK2 overexpression in cell lines, siRNA knockdown of Nmrk1 in AML12 hepatocytes, and a constitutive Nmrk1 knockout mouse.
- NAD+ precursor metabolism was tested in cultured cells, primary hepatocytes, primary brown adipocytes, and mice using NR, NMN, NAM, and NA treatments, plus isotope-labeled compounds for flux analysis.
- Main analyses included NAD+ quantification by assay, targeted LC-MS/LC-QqQ MS metabolomics, western blotting, and qPCR; statistical testing used t-tests or one-way ANOVA with Bonferroni post-test.
## Limitations
- The paper states that data are available only upon request, which limits immediate reproducibility access.
- The text makes evident that several mechanistic claims rely on high-dose precursor injections in mice (e.g., 500 mg kg−1 and 50 mg kg−1), so some in vivo effects may not reflect physiological exposure; this is evident from the text.
- The paper itself notes that future work is needed to better characterize circulating NAD+, NMN, and NR and to optimize organ-targeted formulations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Extracellular NMN dephosphorylates to NR. HepG2 cells were treated with [18O]-labelled NR (a,b) or NMN (c,d). Intracellular enrichment of labelled compounds (a,c) and presence of labelled compounds in the media of treated cells (b,d). Results shown are mean±s.e.m. (n=3).](https://figures.cochat.ai/paper-figures/57e8a39cf3da45969cbff31a92059db8/nrk1-controls-nicotinamide-mononucleotide-and-nicotinamide-riboside-metabolism-figure-4.jpg)

![Figure 6 Extracellular conversion of NMN to NR by hepatocytes. (a) Primary hepatocytes were isolated from 10 to 15 weeks old WT mice. Cells were treated with 2 μM FK866 and ±2 mM CMP for 1 h. Then, 0.5 mM NR or NMN was added and NAD+ was measured after 2 h. (b,c) WT (b) and NRK1KO (c) hepatocytes were treated with [2H]-[13C]-double labelled NR or NMN. Intracellular enrichment of labelled compounds. Results shown are mean±s.e.m., **P<0.01 versus ctrl by two-sided unpaired T-test (n=3).](https://figures.cochat.ai/paper-figures/d72a2197ccbc48f5bcf199a67d302e52/nrk1-controls-nicotinamide-mononucleotide-and-nicotinamide-riboside-metabolism-figure-6.jpg)


Verification
Claims the paper makes
12 Valid · 1 Not valid · 12 Not checked · 97 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Whereas NMN concentration has been reported to reach around 50 μM in plasma14, our study and others13 have failed to detect comparable levels of circulating NMN.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Not checked — no full text of the sourcecites [14] Revollo, J. R. et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6, 363–375 (2007). source
- Supportedcites [13] Hara, N., Yamada, K., Shibata, T., Osago, H. & Tsuchiya, M. Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma. PLoS ONE 6, e22781 (2011). source
The Results section reports that NMN was not detected in freshly prepared mouse plasma by LC/MS/MS, with a detection limit of 50 nM—far below the approximately 50 µM level mentioned in the citing sentence. The Discussion likewise contrasts this nondetection with earlier reports of high plasma NMN concentrations. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In line with this, CD73 silencing blocks the use of NMN as an extracellular NAD+ precursor17.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Partly supportedcites [17] Sociali, G. et al. Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model. Oncotarget 7, 2968–2984 (2015). sourceExperimental — accuracy not yet measured
The Results section (Figure 2D) reports that CD73 silencing reduced by 70% the ability of FK866-treated OVCAR-3 cells to generate intracellular NAD+ from extracellular NMN. This supports impaired use of NMN, but not the claim that silencing completely blocks it. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, the induction of NRK2 in response to cellular damage or stress32 suggests the existence of a demand for circulating NR.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Supportedcites [32] Sasaki, Y., Araki, T. & Milbrandt, J. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J. Neurosci. 26, 8484–8491 (2006). source
The Results section, “Expression of enzymes involved in NAD biosynthesis is induced in response to neuronal injury” (page not provided), reports that Nrk2 expression rose more than 20-fold after axotomy. The Discussion interprets this as part of the neuronal response to stress. The sentence’s suggestion of demand for circulating NR is the citing authors’ inference, not a finding it attributes to this source. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This experiment, conducted in parallel with a human clinical trial at the same effective dose of NR, showed that NR produces the greatest rise in liver NAD+ synthesis, followed by NAM and NA24.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Supportedcites [24] Trammell, S. A. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016). source
The Results section ('NR is the superior hepatic NAD+ precursor vitamin'; page not supplied) says the mouse dose was chosen to be comparable, after body-size adjustment, to an effective human NR dose, and that mice received NR or equimolar NAM and NA. The Discussion (page not supplied) ranks their effects on mouse liver NAD+ as NR, then NAM, then NA. The paper also reports a human clinical trial; it does not establish that the mouse experiment and trial ran at the same time. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, WT mice and NRK1/NRK2DKO displayed comparable increases in NAD+ levels in skeletal muscle after intraperitoneal NR and NMN administration (Supplementary Fig. 3d).”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Results > NRK1KO mice are deficient in NR and NMN utilization in vivo
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 122 claims and every source verdict.
- Probably not a substantial claim. 25
- It may state two separate claims as one. 49
- Borderline: one of the tests for a substantial claim is unclear. 1
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Experimental evidence suggests that blood NA and NAM are able to cross the plasma membrane, while blood NAD+ cannot be taken up by cells directly but needs to be converted to smaller uncharged molecules to enter the cells (Hara et al., 2007; Ratajczak et al., 2016).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Ratajczak et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a previous study, the deficiency of NRK1, which phosphorylates NR to NMN, diminished the increase of NAD+ levels in the liver after oral NMN administration, suggesting that NMN was converted to NR before absorption (11).”
From Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD + synthesis via enterohepatic circulation (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Meanwhile, NR is converted to NMN by NR kinase (NRK), thereby bypassing the NAMPT-mediated step (11, 12).”
From Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD + synthesis via enterohepatic circulation (2025) · cites this paper as [11]
In the citing paper
“Additionally, nicotinamide riboside (NR) integrates in this pathway via the conversion of NR into NMN by nicotinamide riboside kinase 1 (NRK1) or NRK2 (Bieganowski and Brenner, 2004; Ratajczak et al., 2016).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Ratajczak et al., 2016
Citations
Cites
HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS
Berry, M. N., & Friend, D. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.43.3.506 · Cited by 4,424
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085 · cited 1×
“Importantly, sirtuin activation has been associated with an improvement in metabolic efficiency and healthspan in mammals 4,5 .”
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008
Self-citationCantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Self-citationGomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255
Self-citationCantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Self-citationMouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210
Self-citation
Cited by
Items 201–300 of 365
Nagahisa, T., Kosugi, S., & Yamaguchi, S. (2023) · Nutrients · doi:10.3390/nu15061494 · Cited by 15
Nicotinamide riboside activates SIRT5 deacetylation
Curry, A. M., Rymarchyk, S., Herrington, N. B., Donu, D., Kellogg, G. E., & Cen, Y. (2023) · FEBS Journal · doi:10.1111/febs.16887 · Cited by 15
Park, J. S., & Perl, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310749 · Cited by 16
“There is an ongoing debate regarding the role of CD73 in contributing to intracellular levels of NAD+ in human primary cells [199,200].”
BackgroundShadiow, J., Miranda, E. R., Perkins, R. K., Mazo, C. E., Lin, Z., Lewis, K. N., Mey, J. T., Solomon, T. P. J., & Haus, J. M. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00662.2022 · Cited by 15
Fan, T., Qin, J., Du, X., et al. (2024) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.4c00752 · Cited by 14
Devereaux, J., Robinson, A. M., Stavely, R. G., Davidson, M., Dargahi, N., Ephraim, R., Kiatos, D., Apostolopoulos, V., & Nurgali, K. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1379335 · Cited by 16
Ren, C., Shuang, Z., Chen, Y., Deng, K., Kuang, M., Gong, Z., Zhang, K., Wang, P., Huang, P., Zhou, Z., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202400453r · Cited by 18
“30,63,146 Research have shown that in yeast cells, the extracellular conversion of NMN to NR via dephosphorylation is a necessary condition for the efficient utilization of NMN. 148 Studies in NIH/3T3 cells have shown that overexpression of cytoplasmic NRK1 increases NAD + synthesis after adding…”
InfluentialHashimoto, S., Gamage, U. S. K., Inoue, Y., Iwata, H., & Morimoto, Y. (2025) · Scientific Reports · doi:10.1038/s41598-024-81393-z · Cited by 16
Nicotinic acid riboside maintains NAD+ homeostasis and ameliorates aging-associated NAD+ decline
Song, W.-S., Shen, X., Du, K., Ramirez, C. B., Park, S. H., Cao, Y., Le, J., Bae, H., Kim, J., Chun, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.04.007 · Cited by 23
Palmer, R. D., Elnashar, M. M. M., & Vaccarezza, M. (2021) · Aging Medicine · doi:10.1002/agm2.12170 · Cited by 16
“An additional study by Ratajczak et al. (2016)28 shows that NMN is not taken directly into the cell, but first metabolized extracellularly into NR for cellular intake, and then converted into NAD once inside the cell.”
BackgroundCiarlo, E., Joffraud, M., Hayat, F., Giner, M. P., Giroud‐Gerbetant, J., Sanchez-Garcia, J. L., Rumpler, M., Moco, S., Migaud, M. E., & Cantó, C. (2022) · Nutrients · doi:10.3390/nu14132752 · Cited by 15
“This generates NMN, converging then with the classic NAM salvage pathway [21,22].”
BackgroundResultInfluentialSelf-citationPodyacheva, E., & Toropova, Y. G. (2021) · Nutrients · doi:10.3390/nu13103435 · Cited by 17
“NRK1 and NRK2 are encoded by the human genome and by the genomes of other mammalian organisms (encoded by the Nmrk1 and Nmrk2 genes, respectively) [32,33].”
BackgroundInfluentialCross-talk in NAD+ metabolism: insights from Saccharomyces cerevisiae
Raj, C. J. T., & Lin, S.-J. (2019) · Current Genetics · doi:10.1007/s00294-019-00972-0 · Cited by 13
Risks and rewards of targeting NAD+ homeostasis in the brain
Li, C., & Wu, L. E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111545 · Cited by 14
Vuong, C. K., Weber, A., Seong, P., Matoba, N., Chen, Y.-J., Peyer, J., Younesi, S., Salinda, A., Gomez, D., Rivas, G., et al. (2026) · Science · doi:10.1126/science.aea1259 · Cited by 19
Damschroder, D., Perez, R. Z., Richardson, K., Vaz, F. M., Houtkooper, R. H., & Wessells, R. J. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049279 · Cited by 13
Chubanava, S., & Treebak, J. T. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112109 · Cited by 17
“Alternatively, NMN can be synthesized from nicotinamide riboside (NR) via its phosphorylation by NR kinases 1 and 2 (NRK1, NRK2) (Bieganowski and Brenner, 2004; Ratajczak et al., 2016).”
BackgroundU-Din, M., de Mello, V. D., Tuomainen, M. H., Raiko, J. R. H., Niemi, T. S., Fromme, T., Klåvus, A., Gautier, N., Haimilahti, K., Lehtonen, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113131 · Cited by 22
“Mouse studies have shown that NAD + biosynthesis and consumption are likely higher in BAT than WAT, 35 but human data are lacking.”
BackgroundThe elusive NMN transporter is found
Wu, L. E., & Sinclair, D. A. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0015-6 · Cited by 14
Hua, R., Wang, G., Shen, Q., Yang, Y., Wang, M., Wu, M., Shao, Y., He, M., Zang, Y., Yao, Q., et al. (2020) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2020.05.030 · Cited by 13
Nicotinamide mononucleotide: An emerging nutraceutical against cardiac aging?
Wei, Z., Chai, H., Chen, Y., Cheng, Y., & Liu, X. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.08.006 · Cited by 14
Wang, E., Wang, Y., Zhang, Z., Jiang, Y., & Zhao, C. (2025) · Biogerontology · doi:10.1007/s10522-025-10270-7 · Cited by 11
Nicotinamide Antagonizes Lipopolysaccharide-Induced Hypoxic Cell Signals in Human Macrophages
Curran, C. S., Dougherty, E. J., Cui, X., Li, Y., Jeakle, M. M. P., Gamble, T., Demirkale, C. Y., & Torabi‐Parizi, P. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200552 · Cited by 11
Metcalfe, M., David, B. T., Langley, B. C., & Hill, C. E. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114479 · Cited by 12
Chen, Y., Lu, Y., Yang, L., Ma, W., Dong, Y., Zhou, S., Liu, N., Gan, W., & Li, D. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02837-4 · Cited by 11
“NMRK2 is the gene encoding the NAD + precursor (NMN) kinase [18, 19].”
BackgroundNAD+ oscillation and hypothalamic neuronal functions
Tokizane, K., & Imai, S. (2021) · Faculty Reviews · doi:10.12703/r/10-42 · Cited by 11
Saito, Y., Sato, K., Jinno, S., Nakamura, Y., Nobukuni, T., Ogishima, S., Mizuno, S., Koshiba, S., Kuriyama, S., Ohneda, K., et al. (2023) · Nutrients · doi:10.3390/nu16010145 · Cited by 10
“The roles of the NAD precursors nicotinamide (NAM) and nicotinic acid (NA) have long been studied, but nicotinamide riboside (NR) and NMN have recently received attention as more-effective NAD precursors for raising NAD levels than NA and NAM [18,19].”
BackgroundResultMetabolism and Receptor Mechanisms of Niacin Action
Boronovskiy, S. E., Сергеевна, К. В., & Nartsissov, Y. R. (2024) · Cell and Tissue Biology · doi:10.1134/s1990519x23700025 · Cited by 13
“Under stress conditions that lead to a drop in NAMPRT levels, NRK2 levels increase significantly, which appears to allow NR to be used as a source of NAD when NAM-induced synthesis becomes ineffective.”
InfluentialKong, L., Li, X., Liu, T., Yao, Q., & Qin, J. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1492179 · Cited by 10
Habeichi, N. J., Ghali, R., Mroueh, A., Kaplan, A., Tannous, C., Jurjus, A. R., Amin, G., Mericskay, M., Booz, G. W., EL‐Yazbi, A. F., et al. (2022) · Clinical Science · doi:10.1042/cs20220513 · Cited by 11
Metabolic predictors of response to immune checkpoint blockade therapy
Shorer, O., & Yizhak, K. (2023) · iScience · doi:10.1016/j.isci.2023.108188 · Cited by 11
“46 MGAT4A is an N-acetylglucosaminyltransferase which attaches N-acetylglucosamine (GlcNAc) to the nitrogen atom of an asparagine side-chain, thus playing a crucial role in the regulation of many intracellular and extracellular functions.”
BackgroundBiological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers
Myong, S., Nguyen, A. Q., & Challa, S. (2024) · Cancers · doi:10.3390/cancers16173085 · Cited by 10
“CD73 consumes NMN and converts it to NR [117], which then becomes internalized and converted back to NMN by nicotinamide riboside kinases (NRK1/2) (Figure 1C) [118].”
BackgroundQiu, S., Zhang, Y., 邵诗涵, Zhang, Y., Yin, J., Xu, X., Yang, J. J., Hong, Y., Yang, J., Tan, X., et al. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101655 · Cited by 16
“NMN and NR are natural compounds that effectively enhance NAD + biosynthesis which bypasses the rate-limiting enzyme NAMPT [13].”
BackgroundNicotinamide Riboside Derivatives: Single Crystal Growth and Determination of X-ray Structures
Alvarez, R., Schabert, G., Soydemir, A., Wick, L., Spitz, U. P., & Spingler, B. (2019) · Crystal Growth & Design · doi:10.1021/acs.cgd.9b00423 · Cited by 10
Doig, C. L., Zielinska, A. E., Fletcher, R. S., Oakey, L. A., Elhassan, Y., Garten, A., Cartwright, D., Heising, S., Alsheri, A., Watson, D. G., et al. (2020) · Skeletal Muscle · doi:10.1186/s13395-019-0216-z · Cited by 13
The genomic landscape of pediatric renal cell carcinomas
Beck, P., Selle, B., Madenach, L., Jones, D., Vokuhl, C., Gopisetty, A., Nabbi, A., Brecht, I. B., Ebinger, M., Wegert, J., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104167 · Cited by 10
Quantitative dynamics of intracellular NMN by genetically encoded biosensor
Chen, L., Wang, P., Huang, G., Cheng, W., Liu, K., & Yu, Q. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116842 · Cited by 9
Supplementation with NAD+ Precursors for Treating Alzheimer’s Disease: A Metabolic Approach
Alghamdi, M. A., & Braidy, N. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231277 · Cited by 14
“NR is converted to NMN by two nicotinamide ribose kinases, NMRK1 and NMRK2 (or NRK1 and NRK2) [67].”
Xing, S., Kang, X., Wang, R., Wang, C., Wang, Y., Bao, X., & Zhao, J. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.5c00038 · Cited by 9
Arizono, I., Fujita, N., Tsukahara, C., Sase, K., Sekine, R., Jujo, T., Otsubo, M., Tokuda, N., & Kitaoka, Y. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45090449 · Cited by 12
“Exogenous NR can be converted to NAD + via nicotinamide riboside kinase 1 (NRK1) in mammalian tissues [35].”
BackgroundThe female mouse is resistant to mild vitamin B3 deficiency
van der Stelt, I., Shi, W., Bekkenkamp‐Grovenstein, M., Perez, R. Z., Houtkooper, R. H., de Boer, V. C. J., Hegeman, M. A., & Keijer, J. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02651-8 · Cited by 9
Xie, X., Kong, Q., Chen, Y., Yang, Z., Wu, Z., Xiao, Y., Chen, Y., Yu, Z., Luo, X., & Qu, W. (2024) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2024.100111 · Cited by 8
Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling
Kao, G., Zhang, X., Nasertorabi, F., Katz, B. B., Li, Z., Dai, Z., Zhang, Z., Zhang, L., Louie, S. G., Cherezov, V., et al. (2024) · JACS Au · doi:10.1021/jacsau.4c00695 · Cited by 9
An overview of engineering microbial production of nicotinamide mononucleotide
Li, B., Meng, X., & Liu, W. (2024) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2024.10.014 · Cited by 8
Chen, F., Zhou, D., Kong, A. P.-S., Yim, N. T., Dai, S., Chen, Y., & Hui, L. L. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01557-z · Cited by 10
“However the uptake pathway of NMN in cells and tissues is still controversial, [12, 13] and thus it is not clear whether oral supplementation of NMN in humans improves glucose control and lipid profile.”
Zhang, M., Jia, H., Zhuang, L., Xu, Y., Zhang, T., Gu, J., He, S., & Li, D. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114450 · Cited by 8
Cai, C., Yang, P., Shi, Y., et al. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110150 · Cited by 8
CD38 mediates nicotinamide mononucleotide base exchange to yield nicotinic acid mononucleotide
Madawala, R. J., Banks, J. L., Hancock, S. E., Quek, L., Turner, N. A., & Wu, L. E. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108248 · Cited by 9
“NMN enters the cell following its extracellular dephosphorylation into NR (61) and its incorporation into the NAD + metabolome is blocked by deletion of NRK enzymes (62), with controversy around the existence of an intact NMN transporter (63 – 65).”
Protein Engineering and Dual-Module Optimization for Efficient NMN Production in E. coli
Ma, X., Wang, Q., Chen, K., Shen, Y., Guan, J., Xu, M., Rao, Z., & Zhang, X. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c00043 · Cited by 9
Niacinamide and Neuroprotection: The Glaucoma Holy Grail
Bhartiya, S. (2023) · JOURNAL OF CURRENT GLAUCOMA PRACTICE · doi:10.5005/jp-journals-10078-1390 · Cited by 8
Recent Advances in the Chemical Synthesis of β-Nicotinamide Mononucleotide
Ming, W., Hu, S., Liu, Y., Li, Q.-A.-W., Zhu, Y., & Gu, S.-X. (2023) · Current Organic Chemistry · doi:10.2174/1385272827666230201103848 · Cited by 9
A ketogenic diet can mitigate SARS-CoV-2 induced systemic reprogramming and inflammation
Palermo, A., Li, S., ten Hoeve, J., Chellappa, A., Morris, A., Dillon, B. J., Ma, F., Wang, Y., Cao, E. Z., Shabane, B., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05478-7 · Cited by 12
“Therefore, in cardiac tissues a KD can mitigate NAD + salvage induced by the virus 38 .”
Pérez-Rodríguez, M., García‐Verdugo, A., Sánchez‐Mendoza, L. M., Muñoz-Martín, A. B., Bolaños, N., Pérez‐Sánchez, C., Moreno, J. A., Burón, M. I., de Cabo, R., González-Reyes, J. A., et al. (2024) · Aging Cell · doi:10.1111/acel.14273 · Cited by 9
Miao, C., Zheng, S., Wang, D., Dong, X. W., Guan, Y., Qi, Q., Hu, W., Hong, C., & Zhang, C. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220518113219 · Cited by 8
Nicotinamide phosphoribosyltransferase and the hypothalamic-pituitary-adrenal axis of the rat
Celichowski, P., Jopek, K., Milecka, P., Szyszka, M., Tyczewska, M., Malendowicz, L. K., & Ruciński, M. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8569 · Cited by 9
Development of Second Generation Activity-Based Chemical Probes for Sirtuins
Curry, A. M., Barton, E. E., Kang, W., Mongeluzi, D. V., & Cen, Y. (2020) · Molecules · doi:10.3390/molecules26010011 · Cited by 8
NAD in pathological cardiac remodeling: Metabolic regulation and beyond
Norambuena‐Soto, I., Deng, Y., Brenner, C., Lavandero, S., & Wang, Z. V. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167038 · Cited by 15
Self-citationNMRK2 is an efficient diagnostic indicator for Xp11.2 translocation renal cell carcinoma
Feng, H., Cao, S., Fu, S., Liu, J., Gao, Y., Dong, Z., Cai, T., Wen, L., Xiong, Z., Li, S., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6340 · Cited by 7
Biological production of nicotinamide mononucleotide: a review
Cabulong, R. B., Kafle, S. R., Singh, A., Sharma, M., & Kim, B. S. (2024) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2024.2433993 · Cited by 8
“Another way of synthesizing NMN through the salvage pathway involves using exogenous NR, which can be directly phosphorylated and converted to NMN by the enzyme nicotinamide riboside kinases (NRKs) encoded by the nadR gene [35].”
Programmed axon degeneration: mechanism, inhibition and therapeutic potential
Loreto, A., & Neukomm, L. J. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00986-3 · Cited by 12
Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure
Cercillieux, A., Ratajczak, J., Joffraud, M., Sanchez-Garcia, J. L., Jacot, G. E., Zollinger, A., Métairon, S., Giroud‐Gerbetant, J., Rumpler, M., Ciarlo, E., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101605 · Cited by 10
“Also, muscle harbors NRK2 and high NAMPT content, which could allow sustaining NADþ levels in situations of NRK1 deficiency [27,38].”
BackgroundMethodResultInfluentialSelf-citationBiotechnological production of reduced and oxidized NAD+ precursors
Perez, R. Z., García-Saura, A. G., Scantlebery, A. M. L., Schomakers, B. V., Rabadán-Ros, R., van Weeghel, M., Houtkooper, R. H., & Sánchez‐Ferrer, Á. (2023) · Food Research International · doi:10.1016/j.foodres.2023.112560 · Cited by 7
Nicotinamide riboside–amino acid conjugates that are stable to purine nucleoside phosphorylase
Hayat, F., & Migaud, M. E. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob00134a · Cited by 9
Self-citationSnapshots of nascent RNA reveal cell- and stimulus-specific responses to acute kidney injury
Shen, T. H., Stauber, J., Xu, K. H., Jacunski, A., Paragas, N., Callahan, M., Banlengchit, R., Levitman, A. D., de Oliveira, B. D., Beenken, A., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.146374 · Cited by 9
Differences in Extracellular NAD+ and NMN Metabolism on the Surface of Vascular Endothelial Cells
Jabłońska, P., Mierzejewska, P., Tomczyk, M., Koszałka, P., Frańczak, M., Kawecka, A., Kutryb-Zając, B. A., Braczko, A., Smolenski, R. T., & Slominska, E. M. (2022) · Biology · doi:10.3390/biology11050675 · Cited by 8
“NMN, Nam, and NR metabolites could restore the intracellular NAD+ pool by the NAD+ salvage pathway [23].”
BackgroundComment on “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women”
Brenner, C. (2021) · Science · doi:10.1126/science.abj1696 · Cited by 7
“NR is the largest fragment of NAD that can enter cells to be salvaged; NMN is dephosphorylated extracellularly to NR and depends on the NR kinase pathway for its biosynthesis into NAD coenzymes (11).”
BackgroundSelf-citationZhang, J., Poon, E. T., & Wong, S. H. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2387324 · Cited by 8
“Ratajczak et al. (2016) proposed that the uptake of NMN would undergo extracellular degradation and then recomposition inside the cell, while Mills et al. (2016) reported a rapid absorption and conversion to NAD in liver and muscle, suggesting a direct uptake of NMN by a transporter.”
Nicotinamide restores tissue NAD+ and improves survival in rodent models of cardiac arrest
Zhu, X., Li, J., Wang, H., Gasior, F. M., Lee, C., Lin, S., Justice, C. N., O’Donnell, J. M., & Hoek, T. L. V. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291598 · Cited by 7
NAD+ Acts as a Protective Factor in Cellular Stress Response to DNA Alkylating Agents
Ruszkiewicz, J. A., Papatheodorou, Y., Jäck, N., Melzig, J., Eble, F., Pirker, A., Thomann, M., Haberer, A., Rothmiller, S., Bürkle, A., et al. (2023) · Cells · doi:10.3390/cells12192396 · Cited by 6
“The cellular NMN uptake is under discussion—the recently proposed transporter remains controversial [47,48]—and the leading hypothesis comprises the dephosphorylation of NMN into NR in order to enter the cells [49].”
BackgroundCardoso, D., Barthélémy, I., Blot, S., & Muchir, A. (2023) · Skeletal Muscle · doi:10.1186/s13395-023-00328-w · Cited by 8
“It exists another NAD + precursor—nicotinamide riboside (NR)—which enhances NAD + levels through the salvage pathway when catalyzed by nicotinamide riboside kinase (Nmrk) [4, 27].”
BackgroundNR Supplementation During Lactation: Benefiting Mother and Child
Yang, D., & Wan, Y. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.02.004 · Cited by 8
Hawkins, J., Idoine, R., Kwon, J., Shao, A. E., Dunne, E., Hawkins, E. M., Dawson, K., & Nkrumah-Elie, Y. M. (2024) · medRxiv · doi:10.1101/2024.06.06.24308565 · Cited by 9
“…diabesity, central and peripheral neurodegeneration, mitochondrial disease, alcoholic liver disease, postpartum, coronavirus infection (Samuel A.J. Trammell et al. , 2016; Hamity et al. , 2017; Vaur et al. , 2017; Diguet et al. , 2018; Liu et al. , 2018; Ear et al. , 2019; Parker et al. , 2020;…”
BackgroundInfluentialNicotinamide protects against diabetic kidney disease through regulation of Sirt1
Yang, Y., Huang, J., Xie, L., Wang, Y., Guo, S., Wang, M., Shao, X., Liu, W., Wang, Y., Li, Q., et al. (2024) · Endocrine · doi:10.1007/s12020-024-03721-7 · Cited by 5
“It is important to note that NR is largely degraded in the gastrointestinal tract [14] and circulation [15] to form nicotinamide (Nam) or nicotinic acid (NA).”
BackgroundNicotinamide riboside Induced Energy Stress and Metabolic Reprogramming in BEAS-2B Cells
Cordeiro, E. W. F., Marzola, E. L., Maekawa, R. S., dos Santos, M. R., Assunção, L. G., Massafera, M. P., de Oliveira, J., Batista, T. G. C., de Sales, M. C. O. P., Maria–Engler, S. S., et al. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00312 · Cited by 7
Neutrophils loaded NAD+ impede TLR4/NF-κB/NLRP3 pathway for sepsis treatment
Zhao, Y., Qu, Y., Huang, C., Li, C., Zhang, W., Wang, X., Duan, W., He, Q., Zhang, Y., Jiao, J., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102168 · Cited by 9
“Nevertheless, NAD + , being a negatively charged hydrophilic small molecule, exhibits limited permeability through cellular membranes [11].”
Characterization of Two NMN Deamidase Mutants as Possible Probes for an NMN Biosensor
Camarca, A., Minazzato, G., Pennacchio, A., Capo, A., Amici, A., D’Auria, S., & Raffaelli, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126334 · Cited by 5
“Its presence in plasma remains controversial, as NMN is reported to be undetectable by some authors or to range from 7 nM to about 50 μM by others [3,7,8].”
BackgroundSmall Molecule Regulators Targeting NAD+ Biosynthetic Enzymes
Cen, Y., Curry, A. M., & White, D. S. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210531144629 · Cited by 6
Nutritional Regulation of Mitochondrial Function
Vasam, G., Reid, K., Burelle, Y., & Menzies, K. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811752-1.00004-3 · Cited by 7
Reyna, K., Heinzen, G., Patel, N., Ritter, M., Siojo, A., Legere, H., & Pojednic, R. M. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1652582 · Cited by 7
Acute nicotinamide riboside supplementation increases human cerebral NAD + levels in vivo
Nanga, R. P. R., Wiers, C. E., Elliott, M. A., Wilson, N. E., Liu, F., Cao, Q., Swago, S., Jacobs, P. S., Armbruster, R. R., Reddy, D., et al. (2024) · Magnetic Resonance in Medicine · doi:10.1002/mrm.30227 · Cited by 17
The Role of NAD+ Metabolism in Cardiovascular Diseases: Mechanisms and Prospects
Li, H., Hu, Q., Zhu, D., & Wu, D. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00711-y · Cited by 5
“Under physiological conditions in healthy cardiac tissue, NRK-2 was difficult to detect with protein immunoblotting [13], whereas NRK-2 expression dramatically increases in mouse and human ischemic heart, limiting hypoxia/re-oxygenation-induced cardiomyocyte death [14], and NRK-2 is critical for…”
Need for NAD+: Focus on Striated Muscle Laminopathies
Cardoso, D., & Muchir, A. (2020) · Cells · doi:10.3390/cells9102248 · Cited by 5
“NMNATs are also interesting targets for raising NAD+ because of their contribution of both de novo and salvage pathways [22,105].”
BackgroundInfluentialNicotinamide riboside kinase 2: A unique target for skeletal muscle and cardiometabolic diseases
Ahmad, F., & Qaisar, R. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167487 · Cited by 8
Li, Y., Tong, Y., Xie, R., Zhang, Z., Islam, Z. H., Zhang, K., Burger, J., Hoyt, N. E., Kent, E. W., Marcum, W. A., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.045 · Cited by 7
The Physiological Effects of Visfatin on Immune Response and Inflammatory Impacts on Nephropathy.
Obaidi, R. M. S. A. (2021) · PubMed Central · doi:10.22092/ari.2021.355463.1688 · Cited by 4
“NAMPT has been demonstrated to be a key NAD biosynthesis enzyme in mammalian cells, as it controls the activity of the SIRT-1 enzyme (7).”
BackgroundBaquero, F., del Campo, R., & Martínez, J. L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.861603 · Cited by 4
“Mammalian cells cannot import NAD+; so that commercial oral NAD-boosting supplements have been developed, using exogenous NAD precursors, such as L-tryptophane, nicotinic acid, nicotinamide-mononucleotide, nicotinamide-riboside, and dihydronicotinamide-riboside (Ratajczak et al., 2016; Sinclair, 2018; Reiten et al., 2…”
BackgroundKahn, B., Borrelli, M. R., & Libby, T. J. (2022) · Journal of Drugs in Dermatology · doi:10.36849/jdd.6870 · Cited by 4
Neamţu, A. S., Biţă, A., Scorei, I. R., Rău, G., Bejenaru, L. E., Bejenaru, C., Rogoveanu, O.-C., Oancea, C. N., Radu, A., Pisoschi, C. G., et al. (2019) · Acta Chromatographica · doi:10.1556/1326.2019.00600 · Cited by 5
Fan, Y., Qing-yun, H., Wu, X., Lang, P., Wei, Y., Yi, R., He, C., Geng, T., Zhao, C. L., Zhou, S., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202500921r · Cited by 4
“Additionally, NMN is transported across the plasma membrane via SLC12A8 or incorporated into cells through equilibrative nucleoside transporters after extracellular conversion to nicotinamide riboside [40, 41].”
Li, Y., Zhang, C., Li, Z., Bai, F., Jing, Y., Ke, H., Zhang, S., Yan, Y., & Yu, Y. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46020082 · Cited by 3
“NR, as an effective NAD + precursor, has a two-step or three-step pathway to form NAD + and its precursors, which must be converted into NR or NAM before entering cells [40].”
BackgroundMetabolic targets in cardiac aging and rejuvenation
Liu, C., Zhang, X., Hu, M., Lu, Y., Gokulnath, P., Vulugundam, G., & Xiao, J. (2022) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.31 · Cited by 3
NAD+ dyshomeostasis in RYR1-related myopathies
Lawal, T. A., Riekhof, W., Groom, L. A., Varma, P., Chrismer, I. C., Kokkinis, A. D., Grunseich, C., Witherspoon, J. W., Razaqyar, M. S., Sinaii, N., et al. (2025) · Skeletal Muscle · doi:10.1186/s13395-025-00390-6 · Cited by 3
“…is preferentially utilized by skeletal muscle cells for salvage pathway-driven NAD + biosynthesis, and has favorable pharmacokinetic and pharmacodynamic properties compared to other precursor compounds such as nicotinic acid (NA), nicotinamide (NAM), and nicotinamide mononucleotide (NMN) [24, 25].”
From Bench to Clinic: The 2024 FASEB Scientific Research Conference on NAD Metabolism and Signaling
Imai, S., Pirinen, E., Sack, M. N., Treebak, J. T., Tzoulis, C., Bruzzone, S., Guse, A. H., Hottiger, M. O., & Cambronne, X. A. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01394-0 · Cited by 2
“Further, he cited research that showed that NR and NMN are transported through distinct carriers (Grozio et al. 2019; Kropotov et al. 2021; Ratajczak et al. 2016).”
NAD + in fatty liver disease: mechanistic insights and associated targets
Guo, Y.-X., Wang, Y., Wu, S., Wang, Y., & Liu, X. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10106-7 · Cited by 4
“Evidence indicates that NAMPT is the rate-limiting enzyme in NAD + synthesis in mammals and that its expression is dynamically regulated under cellular stress conditions, including DNA damage and starvation (Wen et al. 2024; Ratajczak et al. 2016).”
Richard, J., Lizzo, G., Rochat, N., Jouary, A., Silva, P. T., Parisi, A., Christen, S., Moco, S., Orger, M. B., & Gut, P. (2026) · JCI Insight · doi:10.1172/jci.insight.181812 · Cited by 3
NAD⁺ circuits in aging, tissue repair and fibrosis
Izadpanah, R., Rappaport, J., & Alt, E. U. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103305 · Cited by 6
Effect of Phosphoribosyltransferase Down-regulation on Malignant Glioma Cell Characteristics
Kamada, M., Ikeda, K., & Manome, Y. (2020) · Anticancer Research · doi:10.21873/anticanres.14492 · Cited by 2
Yang, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91617-2.00001-8 · Cited by 3
Fan, Y., Wei, Z., Zhang, Y., & Duan, X. (2024) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-024-04982-8 · Cited by 2
“Research also indicates that L-Asn is integral to tumor therapy, as it can effectively mitigate apoptosis induced by high-glutamine inhibition, thereby serving as a potential therapeutic agent [7, 8].”
Cao, X., Jin, L., Yang, H., Yu, L., Wang, Q., Yu, M., Guo, Q., Chen, X. S., & Mao, Z. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.165970 · Cited by 3
Metadata
- Authors
- Ratajczak, J., Joffraud, M., Trammell, S. A. J., Ras, R., Canela, N., Boutant, M., Kulkarni, S. S., Rodrigues, M., Redpath, P., Migaud, M. E., Auwerx, J., Yanes, O., Brenner, C., & Cantó, C.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- University of Iowa (US)
- Centre for Omic Sciences (ES)
- Queen's University Belfast (GB)
- Corresponding author
- Brenner, Charles
- Cantó, Carles
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-11
- Volume
- 7
- Issue
- 1
- Pages
- 13103-13103
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5476803
- OpenAlex
- W2531686927
- Cited by
- 378
- References
- 46
- Citations by year
- 2026: 34 · 2025: 35 · 2024: 48 · 2023: 46 · 2022: 38 · 2021: 40 · 2020: 31 · 2019: 43 · 2018: 28 · 2017: 31 · 2016: 2
- FWCI
- 19.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Roy J. Carver Charitable Trust
- École Polytechnique Fédérale de Lausanne
- National Institutes of Health
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council (BB/N001842/1)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Heart, Lung, and Blood Institute (R01HL108379)
- National Institute of General Medical Sciences (T32GM008629)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Keywords
- nicotinamide mononucleotide, nicotinamide riboside, NAD+ synthesis, NAD+ precursors, sirtuins, poly(ADP-ribose) polymerase, NAD+ supplementation
- MeSH terms
- Animals, Humans, Injections, Intraperitoneal, Mammals, NAD, Niacinamide, Nicotinamide Mononucleotide, Pyridinium Compounds, Phosphotransferases (Alcohol Group Acceptor), Mice, Knockout, Hepatocytes, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.